Company / SG&A per Share
Innoviva, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.81
FY2025
5-year range
$0.16 / $1.83
FY2021-FY2025
Trend
-1.0%
vs FY2024
Sector context
#86 of 210
Health Care
What the data says
At $1.81, Innoviva, Inc.'s sg&a per share ranks #125 of 210 in the Health Care sector. SG&A per Share has fluctuated over the past 10 years, ranging from $0.14 in FY2020 to $1.83 in FY2024.
Based on SEC 10-K filings.
1.81 in FY2025 with a 5-year CAGR of +67.5%.
Increased from $1.42 to $1.81 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +108.5%
- 5-Year CAGR
- +67.5%
- 10-Year CAGR
- -
Sector benchmark
#125 of 210 in Health CareTop 59% of 210This company $1.81 Sector average $29.50
▼
-93.9% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 1.0% year-over-year.
- Ranks #86 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2024.
- Lowest sg&a per share in the period was in FY2020.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.81 | -1.0% |
| FY2024 | $1.83 | +28.7% |
| FY2023 | $1.42 | +611.4% |
| FY2022 | $0.20 | +25.0% |
| FY2021 | $0.16 | +16.5% |
| FY2020 | $0.14 | -57.0% |
| FY2019 | $0.32 | +39.1% |
| FY2018 | $0.23 | -18.0% |
| FY2017 | $0.28 | +35.1% |
| FY2016 | $0.21 | +7.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026